A healthcare market entry strategy takes more than a great product. It requires the right language for every stakeholder in the room, a navigation strategy for procurement that doesn’t take three years, and a partner who has done this before. That’s us.
Healthcare has its own language, its own buying processes, its own compliance considerations, and its own cast of stakeholders who all have to say yes before anything moves. Clinical, administrative, financial, IT, and compliance can all be in the same decision, and they all need to hear a different version of your value story.
I’ve spent years working in and alongside healthcare organizations. I know how hospitals make buying decisions. I know how health plans think about ROI. I know what language gets a CIO interested versus what language gets your email deleted, and I know what it takes to get from “interesting” to “we’re signing.”
Most healthcare market entry strategies fail because they treat healthcare like a vertical with a slightly longer sales cycle. It isn’t. It’s a fundamentally different operating environment, and the companies that win here understand that from day one.
There is no one-size-fits-all strategy here. A digital health startup selling to self-insured employers is navigating a completely different market than a health IT company selling to regional health systems. We start by understanding exactly where your product fits, then build the entry strategy around that specific opportunity.
We identify the specific segment of healthcare where your product has the strongest fit and the clearest value story. Health systems, physician groups, patients, or some combination. We get specific before we get broad.
We map the complete buying committee for your segment, the champions, the economic buyers, the clinical validators, and the blockers. Every role gets a profile: what they care about, what they fear, and how they define success.
We translate your existing positioning into healthcare language. This isn’t a rewrite. It’s a recalibration that emphasizes the evidence, outcomes, and workflow considerations that make healthcare buyers listen.
Where are you going to get traction first? We identify the conferences, associations, accelerators, and partnership channels that give you access to the right conversations without a two-year cold outreach campaign.
Healthcare buyers want proof before they commit. We build the pilot program structure, the case study development framework, and the reference story templates that turn early wins into the social proof that unlocks the next opportunity.
Once you’ve proven the model, we plan the expansion. New segments, new geographies, new product lines. We build the next-phase GTM while you’re executing the current one, so you’re never starting from zero.
This engagement is for health tech companies who have a product that works and a healthcare market that hasn’t quite opened up yet. For digital health startups who are getting meetings but not closing. For life sciences companies who are launching a new product into a segment they haven’t worked in before.
It’s also for technology companies outside of healthcare who see a clear opportunity in the sector and need a guide for the first time through the door. If you’re going into healthcare, go in with a plan.
See it in practice: How I helped Greenway Health restore customer trust and drive product adoption, from my in-house work leading the Intergy Transformation Plan.
Related reading: Why Health Tech Startups Stall at the Buyer (And How to Get Unstuck)
It’s the plan for how a product gets adopted in healthcare: which segment to enter first, who the real buyers and influencers are, what each of them needs to hear, which channels open doors, and what proof you need before you scale. It turns a good product into one that health systems, practices, and payers can actually say yes to.
Healthcare buying decisions involve more people than most markets. Clinical leaders, finance, IT, compliance, and procurement all weigh in, and each one is evaluating risk differently. Without messaging and proof for every stakeholder, deals stall even when the product is strong.
Yes. I’ve done marketing work in telehealth, and digital health companies are a core part of who this engagement is built for, whether you’re selling to providers, health systems, employers, or patients directly.
Yes. Independent practices and clinics are competing for patients who now shop for care like consumers. I help practices sharpen their message, update how they show up online, and build a plan that turns visibility into booked appointments.
Absolutely. Non-endemic and technology companies bring fresh ideas to healthcare, but they often underestimate the language, regulation, and trust the sector demands. I help you translate what you do into terms healthcare buyers recognize and trust.
Tell me what you’re working on. I’ll review it and recommend the right next step, whether that’s a focused advisory hour, a scoped project, or ongoing support.